146 related articles for article (PubMed ID: 12696623)
1. Correlation of risk categorization in gestational trophoblastic tumor between old and new combined staging and scoring system.
Tocharoenvanich S; Chichareon S; Wootipoom V; Bu-ngachat R; Piyananjarassri K
J Obstet Gynaecol Res; 2003 Feb; 29(1):20-7. PubMed ID: 12696623
[TBL] [Abstract][Full Text] [Related]
2. Dynamic staging and risk factor scoring for gestational trophoblastic disease.
Kohorn EI
Int J Gynecol Cancer; 2007; 17(5):1124-30. PubMed ID: 17386047
[TBL] [Abstract][Full Text] [Related]
3. Treatment of gestational trophoblastic neoplasia according to the FIGO 2000 staging and scoring system: a 20 years' experience.
Wang KL; Yang YC; Wang TY; Cheng-Yen Lai J; Chen TC; Chang CL
Acta Obstet Gynecol Scand; 2009; 88(2):204-8. PubMed ID: 19031297
[TBL] [Abstract][Full Text] [Related]
4. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment.
Kohorn EI
Int J Gynecol Cancer; 2001; 11(1):73-7. PubMed ID: 11285037
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients.
Jiang F; Wan XR; Xu T; Feng FZ; Ren T; Yang JJ; Zhao J; Yang T; Xiang Y
Gynecol Oncol; 2018 Jun; 149(3):539-544. PubMed ID: 29653688
[TBL] [Abstract][Full Text] [Related]
6. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy.
Goldstein DP; Zanten-Przybysz IV; Bernstein MR; Berkowitz RS
J Reprod Med; 1998 Jan; 43(1):37-43. PubMed ID: 9475148
[TBL] [Abstract][Full Text] [Related]
7. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
[TBL] [Abstract][Full Text] [Related]
8. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.
Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ
Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
10. Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia.
El-Helw LM; Coleman RE; Everard JE; Tidy JA; Horsman JM; Elkhenini HF; Hancock BW
Gynecol Oncol; 2009 Jun; 113(3):306-11. PubMed ID: 19269684
[TBL] [Abstract][Full Text] [Related]
11. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report.
Kohorn EI
J Reprod Med; 2002 Jun; 47(6):445-50. PubMed ID: 12092012
[TBL] [Abstract][Full Text] [Related]
12. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia.
Ngan HY
Int J Gynecol Cancer; 2004; 14(2):202-5. PubMed ID: 15086715
[TBL] [Abstract][Full Text] [Related]
13. Correlation between clinical staging (FIGO) and prognostic groups with gestational trophoblastic disease.
Smith DB; Holden L; Newlands ES; Bagshawe KD
Br J Obstet Gynaecol; 1993 Feb; 100(2):157-60. PubMed ID: 8386542
[TBL] [Abstract][Full Text] [Related]
14. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.
Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE
Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384
[TBL] [Abstract][Full Text] [Related]
15. [Malignant trophoblastic tumors (MTT) treated in the years 1955-2004 in trophoblastic disease center in the Czech Republic (TDC-CZ): clinical-pathological features, curability, typing, pathogenesis].
Zavadil M; Feyereisl J; Safár P; Pán M
Ceska Gynekol; 2004 Dec; 69 Suppl 1():9-15. PubMed ID: 15748020
[TBL] [Abstract][Full Text] [Related]
16. Remission rates and significance of prognostic factors in gestational trophoblastic tumors.
Ayhan A; Yapar EG; Deren O; Kişnişçi H
J Reprod Med; 1992 May; 37(5):461-5. PubMed ID: 1324312
[TBL] [Abstract][Full Text] [Related]
17. Changes in the management of high-risk gestational trophoblastic neoplasia in the National Trophoblastic Disease Center of Hungary.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Berkowitz RS
J Reprod Med; 2014; 59(5-6):227-34. PubMed ID: 24937962
[TBL] [Abstract][Full Text] [Related]
18. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
[TBL] [Abstract][Full Text] [Related]
19. Staging and assessing trophoblastic tumors. A possible solution to an intractable problem.
Kohorn EI
J Reprod Med; 1998 Jan; 43(1):33-6. PubMed ID: 9475147
[TBL] [Abstract][Full Text] [Related]
20. Dutch Risk Classification and FIGO 2000 for Gestational Trophoblastic Neoplasia Compared.
Eysbouts YK; Massuger L; Thomas C; Ottevanger P; Short D; Harvey R; Sebire N; Kaur B; Naveed S; Sweep F; Seckl M
Int J Gynecol Cancer; 2016 Nov; 26(9):1712-1716. PubMed ID: 27654257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
